ZYXI Overview

Zynex, Inc. is a medical technology company specialized in the manufacturing and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.

Wall Street analysts forecast ZYXI stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ZYXI is USD with a low forecast of 3.70 USD and a high forecast of 3.70 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Zynex Inc revenue for the last quarter amounts to 13.36M USD, decreased -73.26

Zynex Inc. EPS for the last quarter amounts to -1.42 USD, decreased -2128.57

Zynex Inc (ZYXI) has 1000 emplpoyees as of April 01 2026.

Today ZYXI has the market capitalization of 286.93M USD.